OPHTARA
ActiveOPHTARA has been active since 2006 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €419k and a net result of €96k. Equity is growing by ~34% per year across the filed fiscal years. Its solvency ranks better than 31% of 1247 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2024
76
/ 100
Excellent
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2023
Profitability78▲+8
Solvency57▲+11
Growth78=
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €30k at 30 days acceptable
Liquidity short (current ratio 0.94 against 1.16 in 2023; short-term debt: 21.1% and cash: 10.5% of total assets), and 68.5% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
neutral · Filed after the deadline
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 29-08-2025, 29 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
not confirmed
2024
29 d late
2023
90 d late
2022
92 d late
2021
149 d late
2020
128 d late
2019
150 d late
← before the deadline
after the deadline →
Financials · fiscal year 2024, full schema
Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
€96k▲ 517%
2023 · €16k
2018: €-3k
2019: €60k
2020: €88k
2021: €89k
2022: €119k
2023: €16k
2018 → 2024
Working capital
€-16k
2023 · €44k
2018: €-32k
2019: €-129k
2020: €-58k
2021: €81k
2022: €-96k
2023: €44k
2018 → 2024
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20202021202220232024Trend
Equity€129k-€217k▲ 69.1%€307k▲ 41.2%€322k▲ 5.1%€419k▲ 29.8%
Operating result€143k-€144k▲ 0.3%€149k▲ 3.8%€52k▼ 65.2%€152k▲ 193%
Net result€88k-€89k▲ 1.3%€119k▲ 34.5%€16k▼ 87.0%€96k▲ 517%
Result per fiscal year
Operating resultNet result
The operating result recovers in 2024; 2024 is 193% above 2023 and is the highest result in the available series.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €1.33M
Fixed assets
€1.06M▼ 13.0%
Current assets
€263k▼ 16.4%
Equity and liabilities €1.33M
Equity
€419k▲ 29.8%
Debt
€908k▼ 25.3%
The debt ratio falls from 79.0% to 68.5%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€322k▲
2023 · €221k
Cash flow
€266k▲
2023 · €184k
Solvency
31.5%▲
2023 · 21.0%
Current ratio
0.94▼
2023 · 1.16
Quick ratio
0.91▼
2023 · 1.15
Debt / equity
2.17▼
2023 · 3.77
ROE
23.0%▲
2023 · 4.8%
ROA
7.2%▲
2023 · 1.0%
Interest coverage
14.83▲
2023 · 8.80
Debt
€908k▼
2023 · €1.22M
Debt ≤ 1 year
€279k▲
2023 · €271k
Debt > 1 year
€578k▼
2023 · €747k
Income taxes
€35k▲
2023 · €12k
Staff costs
€201k▲
2023 · €197k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2024 against 2023
Balance sheet
Code20232024
Assets
Total assets20/58€1.54M€1.33M▼
Fixed assets21/28€1.22M€1.06M▼
Tangible fixed assets22/27€1.22M€1.06M▼
Land and buildings22€957k€872k▼
Furniture and vehicles24€266k€192k▼
Current assets29/58€315k€263k▼
Stocks and contracts in progress3€4k€10k▲
Stocks30/36€4k€10k▲
Amounts receivable within one year40/41€85k€69k▼
Trade receivables40€33k€6k▼
Other amounts receivable41€51k€64k▲
Cash at bank and in hand54/58€221k€140k▼
Deferred charges and accrued income490/1€5k€45k▲
Equity and liabilities
Total equity and liabilities10/49€1.54M€1.33M▼
Equity10/15€322k€419k▲
Contributions10/11€12k€12k=
Reserves13€157k€157k=
Non-distributable reserves130/1€2k€2k=
Reserves not available under the articles1311€2k€2k=
Distributable reserves133€155k€155k=
Profit (loss) carried forward14€153k€249k▲
Amounts payable17/49€1.22M€908k▼
Amounts payable after more than one year17€747k€578k▼
Financial debts170/4€747k€578k▼
Amounts payable within one year42/48€271k€279k▲
Current portion of amounts payable after more than one year42€167k€169k▲
Trade debts44€46k€43k▼
Suppliers440/4€46k€43k▼
Taxes, remuneration and social security45€58k€68k▲
Taxes450/3€28k€46k▲
Remuneration and social security454/9€30k€22k▼
Other amounts payable47/48€0-
Accrued charges and deferred income492/3€197k€51k▼
Income statement
Code20232024
Remuneration, social security and pensions62€197k€201k▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€169k€170k▲
Other operating charges640/8€11k€11k▼
Non-recurring operating charges66A€0-
Gross operating margin9900€429k€533k▲
Operating profit (loss)9901€52k€152k▲
Financial income75/76B€787€1k▲
Recurring financial income75€787€1k▲
Financial charges65/66B€25k€22k▼
Recurring financial charges65€25k€22k▼
Profit (loss) for the period before taxes9903€28k€132k▲
Income taxes67/77€12k€35k▲
Profit (loss) for the period9904€16k€96k▲
Profit (loss) for the period to be appropriated9905€16k€96k▲
Appropriation of the result
Profit (loss) to be appropriated9906€153k€249k▲
Profit (loss) brought forward from the previous period14P€138k€153k▲
Profit to be distributed694/7€0-
Return on contributions (dividend)694€0-
Social balance
Average headcount (FTE)90874.65.8▲
The notes to these accounts (15 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
2025
29-08
NBB filing
Annual accounts filed
fiscal year 2024 · full schema · 29 days late
2024
29-10
NBB filing
Annual accounts filed
fiscal year 2023 · full schema · 90 days late
2023
31-10
NBB filing
Annual accounts filed
fiscal year 2022 · full schema · 92 days late
2022
31-12
Financial
Highest result since 2018net €119k ▲34.5%
Net result €119k, the highest in the series.
27-12
NBB filing
Annual accounts filed
fiscal year 2021 · full schema · 149 days late
2021
31-12
Financial
Equity above €200kEq €217k ▲69.1%
3 profitable years in a row build equity to €217k.
06-12
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 128 days late
2020
31-12
Financial
Equity above €100kEq €129k ▲214%
2 profitable years in a row build equity to €129k.
28-12
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema · 150 days late
2019
31-12
Financial
Back to profitnet €60k
Net result €60k after one loss-making year.
31-10
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema · 92 days late
2018
15-10
NBB filing
Annual accounts filed
fiscal year 2017 · full schema · 76 days late
30-09
NBB filing
Annual accounts filed
fiscal year 2016 · full schema · 426 days late
2016
30-12
NBB filing
Annual accounts filed
fiscal year 2015 · full schema · 152 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
no sitting director, no change since 2026
We have established no sitting directors for this company. We derive directors from published Gazette acts; while there are none, or none read, nothing appears here. That does not mean the company has none: the CBE keeps its own list of function holders, which we do not read.
19-01-2026
Resigned as Director
19-02-2024
Resigned as Manager
Location & real-estate footprint
Registered office, Brussel · 1 establishment unit since 2006
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Louizalaan 1991050 BrusselGround area
543 m²
Building footprint
541 m²
Volume, LiDAR
7,786 m³
Parcel 21807G0120/00N005, Brussels · tallest building 30.2 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
Louizalaan 199, 1050 Elsene
since 20062.231.870.129
1 parcel
Brussels
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21807G0120/00N005 | Brussels | 543 m² | 1 · 541 m² | 30.2 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
DR. DEBACKER TIBAUT, UROLOOG
BE 0826.742.579
Mechelen · Eq €419k
Dokter Vinciane Guyssens - Inwendige Ziekten - Geriatrie
BE 0832.775.781
Destelbergen · Eq €419k
DOKTER JANIQUE GEUKENS
BE 0878.560.474
Beringen · Eq €418k
Dr. Willem Boer
BE 0715.969.371
Genk · Eq €418k
Bie Schoolmeesters
BE 0859.950.926
Herent · Eq €419k
Of 16,628 companies in sector 86220 we hold annual accounts for 7,973. 6,547 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded09-02-2006
Fiscal year end31-12
Activities, NACEBEL
85120
86210General medical practice
86220Specialist medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 18 filingsAddress and cadastre registers
Data from official sources, last processed on 22-09-2026. Scores and ratios are computed by Checked and are not a credit decision.